Chicken Lips
01 Dec 2016
Re: RNS-First European distributors appo... Thanks Prior. Keep up the direct line.
swisspaul
01 Dec 2016
Re: RNS-First European distributors appo... So just 10 months to wait until we get news on launch then?
theprior
01 Dec 2016
Re: RNS-First European distributors appo... Response from TRX, confirms slippage due to administrative delays in CE process...."Thank you for your email. Yes, you are correct. The slight hold up is a procedural delay with the CE mark approval process, which is unfortunately outside of our control. However, we do still expect that launch of the product will go ahead in H1 2017. "So, nothing to get too concerned about.TP
swisspaul
28 Nov 2016
Re: RNS-First European distributors appo... Nah Riv - you have already pointed out the slippage - job jobbed 
theprior
28 Nov 2016
Re: RNS-First European distributors appo... ps, no doubt sp will have something negative to say, eh sp?
theprior
28 Nov 2016
Re: RNS-First European distributors appointe... Very true GN. But the CE mark promised before 'year end 2016' six months ahead of schedule seems now to have slipped back into H1 2017. I'm still very bullish about TRX but I've emailed them about this slippage and will post reply (if one is received!).This apart, the company has a stable of good quality products, with more to come. It is rapidly boosting sales in the US and, as you have identified, already made progress in Europe even before the CE mark of approval is granted. (There's confidence for you!)Regards, TP
Global Nomad
28 Nov 2016
RNS-First European distributors appointed The move into Europe is falling into place for H1 2017.All good news that should help support an improvement in the sp
theprior
25 Nov 2016
Re: Topped up £631k 6 months to 31 July, £808k FY 2015.just on wound care. Just wait till we start selling other products in US and all products in EUTP
swisspaul
24 Nov 2016
Re: Topped up Positive FDA discussions have also encouraged the Group to apply for a US pilot clinical trial, with submission expected in Q4 2016, signalling a key milestone towards gaining regulatory approval for this product in the US." That should put the sp up a little don't you think?Nope Very expensive sales force in the US at the moment who are generating how much in sales?
theprior
23 Nov 2016
Re: Topped up From RNS 11.07.16 : -"The Group is currently undertaking clinical trials within the EU for both products, and due to the success of the clinical data for OrthoPure™ XT to date, is now expected to gain a CE mark for the product by the end of 2016, more than 6 months ahead of schedule. Positive FDA discussions have also encouraged the Group to apply for a US pilot clinical trial, with submission expected in Q4 2016, signalling a key milestone towards gaining regulatory approval for this product in the US."That should put the sp up a little don't you think?TP
theprior
23 Nov 2016
Re: Topped up The leap in revenue reported in the Interims is the clue to how rapidly this will go. Got funds from other moribund sources. Wouldn't want to get caught with trousers down on this one.We'll see how things pan out as people say, but I'm anticipating great things in the fy report, and maybe a little something in the news before then !!Luck all, TP
waytogo333
23 Nov 2016
Re: Topped up I could also do with topping up on this stock, but not convinced of any immediate urgency either.....
swisspaul
23 Nov 2016
Re: Topped up Riv, I think its gonna be a long wait and that the only bright bit is the possibility of a sale. Its been quite a bit of jam tomorrow and that is also backed up by a broker note to say 'don't expect great things before 2019/20 - I stand to be corrected if someone else can offer an alternative view. Keep your powder dry for more opportunities. as always DYORBest of Luck Swiss
theprior
23 Nov 2016
Topped up Today. Higher volume than norm. I was just reviewing my portfolio and suddenly realised I'd got nowhere near enough of these. Frantically looking for more funds so I can consolidate my position before TRX takes off.Once this breaks the sky's the limit.TP
share 123 maiden
10 Nov 2016
Re: Avita Medical I've had a quick look at Avita Medical's web site and it looks as though the product requires the harvesting of the patient's skin to produce the device, so is not the same as TRX's product although it does cover the same medical condition, i.e. diabetic ulcers. Avita seems to be making progress with the FDA with their product for treating burns patients which looks interesting too. Maybe one for the watch list.Given that both companies are making products that improve patient outcome and reduce costs, I think they have promising futures and the size of the potential market for their products is huge.
